Hirepa 2 (Repaglinide 2 mg)

Product Description

Hirepa 2 contains Repaglinide (2 mg) a fast-acting oral medication designed to manage blood sugar levels in individuals with type 2 diabetes. By stimulating the pancreas to release insulin after meals Repaglinide effectively helps control postprandial blood glucose spikes. This formulation is ideal for patients seeking flexible diabetes management allowing them to adjust their medication based on meal timing.